913375-45-8Relevant articles and documents
Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure
Kawanishi, Nobuhiko,Sugimoto, Tetsuya,Shibata, Jun,Nakamura, Kaori,Masutani, Kouta,Ikuta, Mari,Hirai, Hiroshi
, p. 5122 - 5126 (2007/10/03)
The design of a novel series of cyclin-dependent kinase (CDK) inhibitors containing a macrocyclic quinoxaline-2-one is reported. Structure-based drug design and optimization from the starting point of diarylurea 2, which we previously reported as a modera